Interestingly, compared to the subcutaneously grown tumor, a smaller percentage of CD4+ T cells in the orthotopic grown tumor expressed markers (CD4+ CD39+ CD25+) for a regulatory T cell phenotype (28% vs. 15%, p ≤ 0.01, Figure 4C). This evidence concerns the gene CD4 and neoplasm.